Document is current
Any future updates will be listed below
-
Authors
Shieh, Kevin
Brem, Elizabeth
- License Information
-
More Information
Article History
Received: 21 February 2024
Revised: 4 July 2024
Accepted: 31 July 2024
First Online: 1 October 2024
Competing interests
: EB has participated in Speakers Bureaus for BeiGene, Astra Zeneca, SeaGen, Incyte/Morphosys, and GenMab/AbbVie. She has provided consultancy for Caribou Biosciences, Genetech, Morphosys, BeiGene, ADC Therapeutics, and Astra Zeneca. EB is a member of the Editorial Board of this journal.
